Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Otava Chemicals is an international science-based company specializing in the development and production of screening libraries, building blocks, and complex organic compounds for drug discovery. With over 30 years of experience, the company provides a comprehensive range of services including custom synthesis, molecular modeling, and virtual screening to support pharmaceutical and biotechnology companies worldwide. Their portfolio features over 270,000 screening compounds and specialized libraries targeting specific protein families such as kinases, GPCRs, and ion channels. Otava Chemicals also offers hit-to-lead optimization and medicinal chemistry services to accelerate the early stages of drug development. The company is recognized for its expertise in computational chemistry and its ability to provide high-quality chemical tools for life science research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Otava Chemicals.